EODData

MEMBERSHIP REGISTER LOG IN

TSX, ARCH:

01 Jan 0001
LAST:

0.0000

CHANGE:
 0.00		OPEN:
0.0000		HIGH:
0.0000		ASK:
0.0000		VOLUME:
0
CHG(%):
NaN		PREV:
0.0000		LOW:
0.0000		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

PROFILE

Name:
About:Arch Biopartners Inc., together with its subsidiaries, engages in the development of novel drugs for acute kidney injury and organ damage in Canada. It focuses on developing its lead drug candidate LSALT Peptide, which is in Phase 2 trials to treat inflammation related acute kidney injury experienced by patients undergoing on-pump (bypass) cardiac surgery; and cilastatin to prevent toxin related acute kidney injury via dipeptidase-1. The company also develops CKD Platform, therapeutics targeting chronic kidney disease. Arch Biopartners Inc. is based in Toronto, Canada.
Sector:Healthcare
Industry:Biotechnology
Address:545 King Street West, Toronto, ON, Canada, M5V 1M1
Website:https://www.archbiopartners.com
CUSIP:03938C104
ISIN:CA03938C1041

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download